WallStreetZenWallStreetZen

NYSE: CTV
Innovid Corp Stock Forecast, Predictions & Price Target

Analyst price target for CTV

Based on 3 analysts offering 12 month price targets for Innovid Corp.
Min Forecast
$2.10-4.98%
Avg Forecast
$2.45+10.86%
Max Forecast
$3.00+35.75%

Should I buy or sell CTV stock?

Based on 3 analysts offering ratings for Innovid Corp.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 66.67%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CTV stock forecasts and price targets.

CTV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-16
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-02-27

1 of 1

Forecast return on equity

Is CTV forecast to generate an efficient return?

Forecast return on assets

Is CTV forecast to generate an efficient return on assets?

CTV revenue forecast

What is CTV's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$161.9M+15.73%
Avg 2 year Forecast
$180.5M+29.07%
Avg 3 year Forecast
$198.7M+42.02%
CTV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CTV revenue growth forecast

How is CTV forecast to perform vs Advertising Agencies companies and vs the US market?
Company
13.55%
Industry
0.31%
Market
9.2%
CTV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CTV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CTV vs Advertising Agency Stocks

TickerPricePrice TargetUp/downsideConsensus
CTV$2.21$2.45+10.86%Buy
ADTH$3.19$4.69+47.19%Strong Buy
EEX$6.09$8.20+34.65%Strong Buy
NEXN$5.60$7.60+35.71%Buy
TSQ$11.91$16.83+41.34%Strong Buy

Innovid Stock Forecast FAQ

Is Innovid Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: CTV) stock is to Buy CTV stock.

Out of 3 analysts, 0 (0%) are recommending CTV as a Strong Buy, 2 (66.67%) are recommending CTV as a Buy, 1 (33.33%) are recommending CTV as a Hold, 0 (0%) are recommending CTV as a Sell, and 0 (0%) are recommending CTV as a Strong Sell.

If you're new to stock investing, here's how to buy Innovid stock.

What is CTV's revenue growth forecast for 2024-2026?

(NYSE: CTV) Innovid's forecast annual revenue growth rate of 13.55% is forecast to beat the US Advertising Agencies industry's average forecast revenue growth rate of 0.31%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.2%.

Innovid's revenue in 2024 is $139,882,000.On average, 1 Wall Street analysts forecast CTV's revenue for 2024 to be $22,958,647,868, with the lowest CTV revenue forecast at $22,958,647,868, and the highest CTV revenue forecast at $22,958,647,868. On average, 1 Wall Street analysts forecast CTV's revenue for 2025 to be $25,604,646,147, with the lowest CTV revenue forecast at $25,604,646,147, and the highest CTV revenue forecast at $25,604,646,147.

In 2026, CTV is forecast to generate $28,175,052,578 in revenue, with the lowest revenue forecast at $28,175,052,578 and the highest revenue forecast at $28,175,052,578.

What is CTV's forecast return on assets (ROA) for 2024-2026?

(NYSE: CTV) forecast ROA is N/A, which is lower than the forecast US Advertising Agencies industry average of 0.34%.

What is CTV's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CTV price target, the average CTV price target is $2.45, with the highest CTV stock price forecast at $3.00 and the lowest CTV stock price forecast at $2.10.

On average, Wall Street analysts predict that Innovid's share price could reach $2.45 by Apr 16, 2025. The average Innovid stock price prediction forecasts a potential upside of 10.86% from the current CTV share price of $2.21.

What is CTV's forecast return on equity (ROE) for 2024-2026?

(NYSE: CTV) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.